Inflammation is a key feature of atherosclerosis and its clinical manifestations. The leukocyte
count is a marker of inflammation that is widely available in clinical practice. This paper …

Atherosclerosis is an inflammatory disease, and several inflammatory biomarkers, such as C-
reactive protein, have been used to predict the risk of coronary heart disease. High white …

ContextMyeloperoxidase (MPO), a leukocyte enzyme that promotes oxidation of lipoproteins
in atheroma, has been proposed as a possible mediator of atherosclerosis. ObjectiveTo …

Background—Neutrophils in unstable atherosclerotic lesions have not received much
consideration, despite accumulating evidence suggesting a link between systemic …

Inflammation and oxidative stress contribute to the pathogenesis of many human diseases
including atherosclerosis. Advanced human atheroma contains high levels of the enzyme …

Background Inflammation within vulnerable coronary plaques may cause unstable angina
by promoting rupture and erosion. In unstable angina, activated leukocytes may be found in …

Myeloperoxidase (MPO) is an enzyme stored in azurophilic granules of polymorphonuclear
neutrophils and macrophages and released into extracellular fluid in the setting of …

Myocardial infarction causes significant mortality and morbidity. Timely diagnosis allows
clinicians to risk stratify their patients and select appropriate treatment. Biomarkers have …

Background: Evaluation of patients who present to the hospital with a complaint of chest
pain or other signs or symptoms suggestive of acute coronary syndrome (ACS) is time …

Atherosclerosis is nowadays generally accepted as an inflammatory disease. It is known that
local inflammation occurs in the formation the plaques, as macrophages and other immuno …